Percutaneous coronary intervention (PCI) is effective in opening the infarct related artery
and restoring thrombolysis in myocardial infarction flow 3 (TIMI-flow 3) in large majority of ST …

Introduction: Atherosclerotic coronary artery disease, in particular acute myocardial
infarction (AMI), is a leading cause of morbidity and mortality globally. Percutaneous …

Advances in medical and interventional therapy over the last few decades have
revolutionized the treatment of acute myocardial infarction. Despite the ability to restore …

Current-generation coronary drug-eluting stents are associated with low rates of restenosis
and target lesion revascularization. However, several mechanisms of stent failure remain …

BACKGROUND Reperfusion injury is associated with larger infarct size and drawback of
long-term outcome in patients with acute ST-segment elevation myocardial infarction …

Atheromatous and thrombotic embolization during percutaneous coronary revascularization
is a feared complication that may cause impaired myocardial reperfusion even with a patent …

Background The MGuard™ stent (InspireMD, Tel Aviv, Israel) is a bare metal mesh-covered
stent, developed to prevent no-reflow phenomenon during percutaneous coronary …

В статье представлен обзор современных возможностей неинвазивной и инвазивной
диагностики структуры коронарной бляшки, а также альтернативных методик …

Death rates after acute ST-segment elevation myocardial infarction (STEMI) have fallen
markedly in recent years, however the incidence of heart failure post-MI has remained …

Stenting of the infarct‐related artery during primary percutaneous coronary intervention
(PPCI) allows an optimal restoration of flow and improves patient outcomes. Bare‐metal …